The expression of PD‐1 and PD‐L1 is increased in patients with sepsis, which is associated with a decrease in T cells. Nivolumab reverses T cell exhaustion by blocking PD‐L1 to restore immune cell function, thereby improving immunosuppression. This evidence concerns the gene CD274 and Sepsis.